| Market Cap | 231.67M |
| Revenue (ttm) | 65.56M |
| Net Income (ttm) | -18.44M |
| Shares Out | 36.09M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 284,522 |
| Open | 6.57 |
| Previous Close | 6.54 |
| Day's Range | 6.17 - 6.71 |
| 52-Week Range | 1.81 - 8.06 |
| Beta | 0.37 |
| Analysts | Strong Buy |
| Price Target | 8.00 (+24.61%) |
| Earnings Date | Aug 5, 2025 |
About MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, ... [Read more]
Financial Performance
In 2024, 908 Devices's revenue was $59.63 million, an increase of 18.72% compared to the previous year's $50.23 million. Losses were -$72.21 million, 98.4% more than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for MASS stock is "Strong Buy." The 12-month stock price target is $8.0, which is an increase of 24.61% from the latest price.
News
908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Joseph H. Griffith - CFO & Treasurer Kevin J.
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)-- #VipIR--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech a...
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
BOSTON--(BUSINESS WIRE)-- #CBRN--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Boa...
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applicatio...
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applicatio...
908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances
BOSTON--(BUSINESS WIRE)-- #FTIR--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the launch of VipIR, a 3-in-1 handheld analyzer that sets...
Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500
NORRISTOWN, Pa.--(BUSINESS WIRE)--Asylon, the U.S. leader in robotic security solutions, in collaboration with 908 Devices, the Indianapolis Metropolitan Police Department, and the Indianapolis Motor ...
908 Devices Appoints Christopher D. Brown to its Board of Directors
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, ...
Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit
BOSTON--(BUSINESS WIRE)-- #chemID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments...
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applicatio...
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Gri...
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech application...
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announced that its devices for rapid chemical detection at the point of nee...
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation
BOSTON--(BUSINESS WIRE)-- #chemicalID--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces a $2M order from the Texas Department of Public Saf...
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of He...
908 Devices Makes Key Divestiture (Rating Upgrade)
908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device busines...
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ...
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer i...
908 Devices to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor c...
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and f...
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the...
Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge's bioreactors with 908 Devices' MAVEN for automated control ...
908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Kelly Gura - Gilmartin Group Kevin Knopp - Chief Executive Officer and Co-Founder Joe...
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended Septembe...